"Viral Load" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.
| Descriptor ID |
D019562
|
| MeSH Number(s) |
E01.370.225.875.950 E05.200.875.950 G06.920.850
|
| Concept/Terms |
Viral Load- Viral Load
- Load, Viral
- Viral Burden
- Burden, Viral
|
Below are MeSH descriptors whose meaning is more general than "Viral Load".
Below are MeSH descriptors whose meaning is more specific than "Viral Load".
This graph shows the total number of publications written about "Viral Load" by people in this website by year, and whether "Viral Load" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 4 | 4 |
| 2002 | 0 | 8 | 8 |
| 2003 | 2 | 4 | 6 |
| 2004 | 0 | 6 | 6 |
| 2005 | 1 | 6 | 7 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 8 | 8 |
| 2008 | 0 | 7 | 7 |
| 2009 | 2 | 8 | 10 |
| 2010 | 1 | 13 | 14 |
| 2011 | 0 | 12 | 12 |
| 2012 | 1 | 9 | 10 |
| 2013 | 5 | 11 | 16 |
| 2014 | 2 | 15 | 17 |
| 2015 | 8 | 15 | 23 |
| 2016 | 2 | 14 | 16 |
| 2017 | 7 | 16 | 23 |
| 2018 | 6 | 15 | 21 |
| 2019 | 2 | 6 | 8 |
| 2020 | 3 | 11 | 14 |
| 2021 | 3 | 11 | 14 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 3 | 3 |
| 2024 | 5 | 7 | 12 |
| 2025 | 3 | 4 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Viral Load" by people in Profiles.
-
Retention in HIV Care Still Matters: A Longitudinal Multisite Analysis. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):123-130.
-
Estimating the effect of maternal viral load on perinatal and postnatal HIV transmission: a systematic review and meta-analysis. Lancet. 2025 Jul 26; 406(10501):349-357.
-
Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners. mSphere. 2025 Jul 29; 10(7):e0007425.
-
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20?years in sub-Saharan Africa. Contemp Clin Trials. 2025 Aug; 155:107963.
-
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19. JCI Insight. 2025 Jul 08; 10(13).
-
Low-level viraemia as a risk factor for virologic failure in children and adolescents living with HIV on antiretroviral therapy in Tanzania: a multicentre, retrospective cohort study. J Int AIDS Soc. 2025 May; 28(5):e26474.
-
Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load. PLoS One. 2025; 20(1):e0317033.
-
A novel histologic index for polyomavirus nephropathy in comparison with the Banff scoring system: Clinical validation, prognostic implication, and correlation with plasma viral load. Ann Diagn Pathol. 2025 Apr; 75:152430.
-
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials. J Infect Dis. 2024 Dec 16; 230(6):1384-1389.
-
Viral load suppression and retention in care among children and adolescents receiving multi-month anti-retroviral therapy refills: a program data review in Uganda. BMC Pediatr. 2024 Dec 07; 24(1):804.